论文部分内容阅读
慢心律(Mexiletine Ko1173)或脉律定是近年来合成的抗心律失常药物。其作用快、半衰期长、副作用小,既可静脉注射用于急症抢救。又可长期口服防治心律失常。国外于1972年经动物研究并证明了其抗心律失常的疗效,1973年始应用于临床。我国于1973年由南京药学院合成,继之于北京,安徽、江苏、山东、等
Slow heart rhythm (Mexiletine Ko1173) or pulse law is the recent synthesis of anti-arrhythmic drugs. Its role is fast, long half-life, side effects, intravenous injection can be used for emergency treatment. Long-term oral administration of arrhythmia. Abroad in 1972 by animal studies and proved its anti-arrhythmia efficacy, beginning in 1973 for clinical use. Our country was synthesized by Nanjing Pharmaceutical College in 1973, followed by Beijing, Anhui, Jiangsu, Shandong, etc.